Page last updated: 2024-08-24

imiquimod and Keratosis

imiquimod has been researched along with Keratosis in 80 studies

Research

Studies (80)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	73 (91.25)	29.6817
2010's	7 (8.75)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carstens, E; Carstens, M; Domocos, DT; Follansbee, T; Han, D; Hwang, ST; Shi, Z; Wang, B; Wu, X; Yu, S; Zhou, Y	1
Pickert, A	1
Al Saïf, F; Carmi, E; Dillies, AS; Fraitag-Spinner, S; Gras-Champel, V	1
Akasaka, T; Mori, S	1
Devi, N; Jain, A; Katare, OP; Sharma, G; Thakur, K	1
Caliskan, E; Erbil, AH; Koc, E; Kose, O; Kurumlu, Z	1
Cordoro, KM; Greer, KE; Lonergan, CL; McNamara, EK	1
Cleaver, L; Knabel, P	1
Lebwohl, M; Persaud, A	1
Cervera, C; Lamba, S; Lebwohl, MG; Lou, W; Persaud, AN; Shamuelova, E; Sherer, D; Singer, G	1
Levine, N; Morrison, L; Salasche, SJ	1
Hruza, G	1
Koenig, C; Walker, JK	1
Caglar, S; Crespo, J; Saini, R; Tutrone, WD; Weinberg, JM	1
del Rosso, JQ	3
Eklind, J; Hengge, UR; Lidbrink, P; Maschke, J; Tartler, U	1
Goldberg, LH; Peterson, SR	1
Beyeler, M; Burg, G; Dummer, R; Morcinek, J	1
Rigel, D; Shumack, S	1
Chen, K; Shumack, S; Tran, H	1
Chen, K; Marks, R; Shumack, S; Yap, LM	1
Bianchi, L; Campione, E; Chimenti, S; Costanzo, A; Marulli, GC	1
Alam, M; Goldberg, LH; Silapunt, S	1
Greene, RJ; Harrison, LI; Kurup, S; Marbury, TC; McKane, S; Owens, ML; Skinner, SL	1
Dinehart, S; Fox, TL; Jorizzo, J; Lebwohl, M; Lee, JH; Lee, PK; Tawfik, N; Whiting, D	1
Berman, B; Cazzaniga, A; Davis, SC; Ricotti, CA	1
Campanelli, A; Salomon, D; Saurat, JH	1
Huntley, A; Navi, D	1
Alomar, A; Bichel, J; Fox, TL; Gerritsen, MJ; Gupta, G; Lee, JH; Ortonne, JP; Serresi, S; Szeimies, RM	1
Fein, H; McGillis, ST	1
Arenberger, P; Benninghoff, B; Hengge, UR; Lysa, B; Ruzicka, T; Tartler, U; Walz, M; Wolf, R	1
Benninghoff, B; Christophers, E; Sterry, W; Stockfleth, E	1
Jorizzo, JL	1
Skinner, R	1
Korman, N; Lee, JH; Ling, M; Matheson, R; McKane, S; Moy, R; Smith, S	1
Rivers, JK; Somani, N	1
Andres, KL; Harwell, WB; Lee, JH; Lee, PK; Loven, KH; Phillips, TJ; Whiting, DA	1
Altmeyer, P; Markus, S; Oster-Schmidt, C	1
Haustein, UF; Paasch, U	1
Barnetson, RS; Halliday, GM; Lee, JH; McKane, S; Ooi, T; Slade, HB; Zhuang, L	1
Burkhart, CG	1
Berman, B; Ramirez, CC; Villa, AM	1
Davey, V; Gupta, AK; Mcphail, H	1
Derry, S; Hadley, G; Moore, RA	1
Boonchai, W	1
Berman, B; Bienstock, L; Kuritzky, L; Mayeaux, EJ; Tyring, SK	1
Dissemond, J; Grabbe, S	1
Carrington, PR; D'Addario, S	1
Busch, JO; Meyer, T; Nindl, I; Schmook, T; Sterry, W; Stockfleth, E; Ulrich, C	1
Angelousi, AG; Falagas, ME; Peppas, G	1
Dika, E; Fanti, PA; Miscial, C; Vaccari, S; Varotti, C	1
Tanghetti, E; Werschler, P	1
Dixon, A	1
Alomar, A; Bichel, J; McRae, S	1
Dinehart, S; Fielder, S; Fox, TL; Jorizzo, J; Lee, JH; Ling, M; Matheson, R; McRae, S; Moore, JK	1
Cerroni, L; Kerl, H; Kodama, K; Wolf, IH	1
Cohen, JL; Greenberg, HL; Orengo, I; Rosen, T	1
Ben M'barek, L; Euvrard, S; Frances, C; Lebbe, C; Legendre, C; Mebazaa, A; Menasché, S; Morel, P; Thervet, E	1
Bunker, CB; Singh, S	1
Price, NM	1
Bedwell, SA; Downs, MR; McIntyre, WJ	1
Anders, M; Birmachu, W; Bulbulian, BJ; Jin, J; Lee, J; Miller, RL; Raghavan, S; Slade, HB; Storey, L; Torres, A	1
Ferrándiz, C	1
Amerio, P; Bichel, J; Euvrard, S; Guidi, B; Proby, CM; Rønnevig, J; Slade, HB; Stockfleth, E; Ulrich, C; van de Kerkhof, PC	1
Krawtchenko, N; Mann, I; Roewert-Huber, J; Sterry, W; Stockfleth, E; Ulrich, M	1
Bichel, J; Carey-Yard, M; Sterry, W; Stockfleth, E	1
Germain, M; Hamza, S; Skelton, H; Smith, K	1
Gold, MH	1
Weinberg, JM	1
Arndt, R; Christophers, E; Meyer, T; Röwert, J; Stockfleth, E	1
Steinhorst, M	1
Benninghoff, B; Christophers, E; Meyer, T; Stockfleth, E	1
Hengge, UR; Stark, R	1
Flowers, F	1
Miller, R	1
Eedy, DJ	1

Reviews

23 review(s) available for imiquimod and Keratosis

Article	Year
Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod. Cutis, 2003, Volume: 71, Issue:5 Topics: Administration, Cutaneous; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Fluorouracil; Humans; Imiquimod; Keratosis; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Neoplasms	2003
An update on newer topical therapies for actinic keratoses: advances and applications. Journal of drugs in dermatology : JDD, 2003, Volume: 2, Issue:1 Topics: Administration, Topical; Aminoquinolines; Clinical Trials as Topic; Diclofenac; Humans; Imiquimod; Keratosis; Photosensitivity Disorders	2003
[Cutaneous neoplasms]. Praxis, 2003, Sep-03, Volume: 92, Issue:36 Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Hemangiosarcoma; HIV Infections; Humans; Imiquimod; Immunotherapy; Keratosis; Lymph Node Excision; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Neoplasm Recurrence, Local; Photochemotherapy; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin; Skin Neoplasms; Time Factors	2003
New and emerging topical approaches for actinic keratoses. Cutis, 2003, Volume: 72, Issue:4 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Diclofenac; Humans; Imiquimod; Keratosis; Skin Neoplasms; Treatment Outcome; United States	2003
Treatment of non-melanoma skin cancer: immunotherapy as a viable option. Acta dermato-venereologica. Supplementum, 2003, Issue:214 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Clinical Trials as Topic; Humans; Imiquimod; Keratosis; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays	2003
Summary of actinic keratosis studies with imiquimod 5% cream. The British journal of dermatology, 2003, Volume: 149 Suppl 66 Topics: Adjuvants, Immunologic; Aminoquinolines; Drug Administration Schedule; Humans; Imiquimod; Keratosis; Ointments; Randomized Controlled Trials as Topic; Treatment Outcome; Ultraviolet Rays	2003
Topical and light-based treatments for actinic keratoses. Seminars in cutaneous medicine and surgery, 2003, Volume: 22, Issue:3 Topics: Adjuvants, Immunologic; Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclooxygenase Inhibitors; Diclofenac; Fluorouracil; Humans; Hyaluronic Acid; Imiquimod; Keratosis; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Precancerous Conditions; Retinoids; Skin Neoplasms; Vitamin A	2003
Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Dermatology online journal, 2004, Jul-15, Volume: 10, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Clinical Trials as Topic; Condylomata Acuminata; Drug Screening Assays, Antitumor; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunity, Cellular; Immunologic Factors; Keratoacanthoma; Keratosis; Male; Melanoma; Multicenter Studies as Topic; Mycosis Fungoides; Ointments; Paget Disease, Extramammary; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Neoplasms	2004
Topical treatment strategies for non-melanoma skin cancer and precursor lesions. Seminars in cutaneous medicine and surgery, 2004, Volume: 23, Issue:3 Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photochemotherapy; Precancerous Conditions; Skin Neoplasms; Sunlight	2004
Current and novel treatment options for actinic keratosis. Journal of cutaneous medicine and surgery, 2004, Volume: 8 Suppl 3 Topics: Aminolevulinic Acid; Aminoquinolines; Cryotherapy; Diclofenac; Fluorouracil; Gels; Humans; Imiquimod; Immunosuppressive Agents; Keratosis; Photochemotherapy; Photosensitizing Agents; Treatment Outcome	2004
Role of topical therapies in the management of cutaneous disease. Journal of cutaneous medicine and surgery, 2004, Volume: 8 Suppl 3 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Dermatitis, Atopic; Dermatitis, Seborrheic; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis; Melanoma; Membrane Glycoproteins; Receptors, Cell Surface; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Toll-Like Receptors	2004
[Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2003, Volume: 1, Issue:10 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Middle Aged; Ointments; Precancerous Conditions; Prospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome; Ultraviolet Rays	2003
The use of topical imiquimod for the treatment of actinic keratosis: a status report. Cutis, 2005, Volume: 76, Issue:4 Topics: Administration, Topical; Aminoquinolines; Humans; Imiquimod; Keratosis	2005
Mechanisms of action of new treatment modalities for actinic keratosis. Journal of drugs in dermatology : JDD, 2006, Volume: 5, Issue:2 Topics: Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Antineoplastic Agents; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photochemotherapy; Randomized Controlled Trials as Topic; Teratogens	2006
Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies. Journal of cutaneous medicine and surgery, 2005, Volume: 9, Issue:5 Topics: Adjuvants, Immunologic; Aminoquinolines; Clinical Trials, Phase III as Topic; Confidence Intervals; Facial Dermatoses; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Immunosuppressive Agents; Interferon Inducers; Keratosis; Ointments; Photosensitivity Disorders; Scalp Dermatoses; Time Factors	2005
Imiquimod for actinic keratosis: systematic review and meta-analysis. The Journal of investigative dermatology, 2006, Volume: 126, Issue:6 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratosis; Ointments; Randomized Controlled Trials as Topic; Skin Neoplasms	2006
Actinic keratoses: sequelae and treatments. Recommendations from a consensus panel. The Journal of family practice, 2006, Volume: 55, Issue:5 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Consensus Development Conferences as Topic; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photosensitivity Disorders; Practice Guidelines as Topic; Risk Factors; Skin Neoplasms; Ultraviolet Rays	2006
[Actinic keratosis]. MMW Fortschritte der Medizin, 2006, Jun-15, Volume: 148, Issue:24 Topics: Adjuvants, Immunologic; Age Factors; Aged; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Humans; Imiquimod; Interferon Inducers; Keratosis; Laser Therapy; Male; Ointments; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms; Time Factors; Ultraviolet Rays	2006
Imiquimod for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:3 Topics: Adjuvants, Immunologic; Aminoquinolines; Humans; Imiquimod; Keratosis; Randomized Controlled Trials as Topic	2006
Treatment options for actinic keratoses. American family physician, 2007, Sep-01, Volume: 76, Issue:5 Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Chemexfoliation; Cryosurgery; Curettage; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photochemotherapy; Prevalence; Skin Neoplasms	2007
Update on actinic keratosis in clinical trial experience with imiquimod. The British journal of dermatology, 2007, Volume: 157 Suppl 2 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratosis; Neoplasms, Radiation-Induced; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays	2007
Topical therapy for actinic keratoses: current and evolving therapies. Reviews on recent clinical trials, 2006, Volume: 1, Issue:1 Topics: Administration, Cutaneous; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Colchicine; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Neoplasms, Squamous Cell; Retinoids; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays	2006
Imiquimod: a potential role in dermatology? The British journal of dermatology, 2002, Volume: 147, Issue:1 Topics: Aminoquinolines; Condylomata Acuminata; Dermatologic Agents; Humans; Imiquimod; Interferon Inducers; Keratosis; Skin Diseases; Skin Neoplasms	2002

Trials

21 trial(s) available for imiquimod and Keratosis

Article	Year
Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis. The Journal of dermatological treatment, 2008, Volume: 19, Issue:3 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Administration Schedule; Face; Female; Gels; Humans; Imiquimod; Keratosis; Male; Middle Aged; Severity of Illness Index; Skin; Treatment Outcome; Ultraviolet Rays	2008
Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis. Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:4 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Treatment Outcome	2002
Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trial. Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:4 Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Face; Female; Humans; Imiquimod; Keratosis; Male; Pilot Projects; Scalp; Treatment Outcome	2002
Short-course therapy with imiquimod 5% cream for solar keratoses: a randomized controlled trial. The Australasian journal of dermatology, 2003, Volume: 44, Issue:4 Topics: Administration, Topical; Aged; Aminoquinolines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Emollients; Female; Follow-Up Studies; Humans; Imiquimod; Immunologic Factors; Keratosis; Male; Middle Aged; Probability; Reference Values; Severity of Illness Index; Sunlight; Treatment Outcome	2003
Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms. Archives of dermatological research, 2004, Volume: 296, Issue:1 Topics: Absorption; Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Arm; Facial Dermatoses; Female; Hand; Humans; Imiquimod; Keratosis; Male; Middle Aged; Scalp Dermatoses	2004
Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. Journal of the American Academy of Dermatology, 2004, Volume: 50, Issue:5 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Double-Blind Method; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Ointments; Pharmaceutical Vehicles; Photosensitivity Disorders; Ultraviolet Rays	2004
Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. Journal of the American Academy of Dermatology, 2004, Volume: 51, Issue:4 Topics: Aged; Aminoquinolines; Confidence Intervals; Double-Blind Method; Female; Humans; Imiquimod; Keratosis; Male; Photosensitivity Disorders	2004
Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study. Archives of dermatology, 2004, Volume: 140, Issue:12 Topics: Adjuvants, Immunologic; Aminoquinolines; Double-Blind Method; Follow-Up Studies; Humans; Imiquimod; Incidence; Keratosis; Ointments; Photosensitivity Disorders; Secondary Prevention	2004
Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Archives of dermatology, 2005, Volume: 141, Issue:4 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Keratosis; Male; Middle Aged; Ointments; Precancerous Conditions; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Skin Neoplasms; Statistics, Nonparametric; Treatment Outcome	2005
Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2005, Volume: 31, Issue:6 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Dose-Response Relationship, Drug; Female; Humans; Imiquimod; Keratosis; Male; Treatment Outcome	2005
Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial. The British journal of dermatology, 2006, Volume: 154, Issue:1 Topics: Aged; Aminoquinolines; Biomarkers; Cell Movement; Dendritic Cells; Double-Blind Method; Drug Eruptions; Erythema; Female; Humans; Imiquimod; Immunophenotyping; Interferon Inducers; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Skin; T-Lymphocyte Subsets; Treatment Outcome	2006
Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases. The British journal of dermatology, 2006, Volume: 155, Issue:2 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Drug Administration Schedule; Humans; Imiquimod; Immunocompromised Host; Immunologic Factors; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Pilot Projects; Precancerous Conditions; Skin Neoplasms; Transplants; Treatment Outcome	2006
Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:2 Topics: Administration, Topical; Adult; Aminoquinolines; Disease Management; Erythema; Facial Dermatoses; Fluorouracil; Humans; Imiquimod; Keratosis; Scalp Dermatoses; Treatment Outcome	2007
Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head. The British journal of dermatology, 2007, Volume: 157, Issue:1 Topics: Aged; Aged, 80 and over; Aminoquinolines; Double-Blind Method; Female; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Middle Aged; Ointments; Photosensitivity Disorders; Scalp Dermatoses; Skin Neoplasms; Sunlight; Treatment Outcome	2007
Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head. Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:2 Topics: Adult; Aminoquinolines; Double-Blind Method; Drug Administration Schedule; Facial Dermatoses; Female; Humans; Imiquimod; Keratosis; Male; Ointments; Photosensitivity Disorders; Recurrence; Scalp Dermatoses; Treatment Outcome	2007
The treatment of actinic keratoses with a combination of 5-fluorouracil and imiquimod creams. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:8 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Emollients; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Immunosuppressive Agents; Keratosis; Male; Middle Aged; Patient Dropouts; Time Factors; Treatment Outcome	2007
Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod. The British journal of dermatology, 2007, Volume: 157, Issue:6 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Gene Expression; Humans; Imiquimod; Keratosis; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Photosensitivity Disorders; Scalp Dermatoses; Toll-Like Receptor 7; Treatment Outcome	2007
Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients. The British journal of dermatology, 2007, Volume: 157 Suppl 2 Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imiquimod; Immunocompromised Host; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Organ Transplantation; Skin Neoplasms; Treatment Outcome	2007
A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. The British journal of dermatology, 2007, Volume: 157 Suppl 2 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryosurgery; Esthetics; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Immunocompetence; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays	2007
Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head. The British journal of dermatology, 2007, Volume: 157 Suppl 2 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Facial Neoplasms; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Patient Compliance; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays	2007
Does imiquimod histologically rejuvenate ultraviolet radiation-damaged skin? Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:12 Topics: Aminoquinolines; Biopsy; Dermatologic Agents; Female; Humans; Imiquimod; Immunohistochemistry; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Pilot Projects; Rejuvenation; Signal Transduction; Skin; Skin Aging; Skin Diseases; Sunlight; Ultraviolet Rays	2007

Other Studies

36 other study(ies) available for imiquimod and Keratosis

Article	Year
Transient receptor potential ankyrin 1 (TRPA1) positively regulates imiquimod-induced, psoriasiform dermal inflammation in mice. Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:7 Topics: Adult; Animals; Dermis; Epidermis; Female; Gene Expression Regulation; Humans; Imiquimod; Inflammation; Keratosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Physiologic; Psoriasis; RNA, Messenger; Th17 Cells; TRPA1 Cation Channel	2019
Treatment of actinic keratoses. Cutis, 2012, Volume: 90, Issue:1 Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Combined Modality Therapy; Cryosurgery; Diclofenac; Humans; Imiquimod; Keratosis; Remission Induction; Sunlight	2012
[Eruptive epidermoid cysts during topical imiquimod treatment]. Annales de dermatologie et de venereologie, 2017, Volume: 144, Issue:3 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Diagnosis, Differential; Eyebrows; Humans; Imiquimod; Keratosis; Male; Pruritus; Skin Neoplasms	2017
Imiquimod-induced vitiligo-like hypopigmentation after treatment for radiation keratosis. Clinical and experimental dermatology, 2016, Volume: 41, Issue:8 Topics: Adjuvants, Immunologic; Aminoquinolines; Dermatologic Agents; Humans; Hypopigmentation; Imiquimod; Keratosis; Male; Middle Aged; Radiation Injuries	2016
Lanolin-based organogel of salicylic acid: evidences of better dermatokinetic profile in imiquimod-induced keratolytic therapy in BALB/c mice model. Drug delivery and translational research, 2018, Volume: 8, Issue:2 Topics: Administration, Topical; Aminoquinolines; Animals; Disease Models, Animal; Drug Carriers; Excipients; Gels; Imiquimod; Keratolytic Agents; Keratosis; Lanolin; Male; Mice, Inbred BALB C; Salicylic Acid; Skin; Skin Absorption	2018
Imiquimod cream 5% for the treatment of arsenic-induced cutaneous neoplasms. Cutis, 2010, Volume: 85, Issue:4 Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Arsenic; Carcinoma, Squamous Cell; Follow-Up Studies; Humans; Imiquimod; Keratosis; Male; Neoplasm Recurrence, Local; Psoriasis; Skin Neoplasms	2010
Arbor cutis: hyperkeratotic plaque secondary to the use of imiquimod for the treatment of squamous cell carcinoma in situ. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:4 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Eruptions; Female; Forearm; Humans; Imiquimod; Keratosis; Skin Neoplasms	2013
Imiquimod cream in the treatment of actinic keratoses. Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:4 Suppl Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Sunlight	2002
New treatments for actinic keratoses. Connecticut medicine, 2002, Volume: 66, Issue:10 Topics: Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Dermatologic Agents; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Sunscreening Agents; United States	2002
Catching skin cancer early. New treatments aim to keep keratoses from developing into invasive cancer. Health news (Waltham, Mass.), 2002, Volume: 8, Issue:12 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Humans; Imiquimod; Keratosis; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms	2002
Is imiquimod effective and safe for actinic keratosis? The Journal of family practice, 2003, Volume: 52, Issue:3 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Evidence-Based Medicine; Humans; Imiquimod; Keratosis; Photosensitivity Disorders; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Safety; Skin Neoplasms	2003
Imiquimod to treat different cancers of the epidermis. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2003, Volume: 29, Issue:8 Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Humans; Imiquimod; Keratosis; Male; Neoplasms, Basal Cell; Skin Neoplasms	2003
New and emerging treatments for nonmelanomas and actinic keratoses. Journal of drugs in dermatology : JDD, 2003, Volume: 2, Issue:4 Topics: Adjuvants, Immunologic; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diclofenac; Humans; Imiquimod; Keratosis; Photochemotherapy; Skin Neoplasms	2003
Actinic keratosis treated with an immune response modifier: a case report of six patients. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Treatment Outcome	2003
Determination of the area of skin capable of being covered by the application of 250 mg of 5% imiquimod cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2004, Volume: 30, Issue:5 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Animals; Condylomata Acuminata; Female; Humans; Imiquimod; Keratosis; Swine	2004
Imiquimod (Aldara) for actinic keratoses. The Medical letter on drugs and therapeutics, 2004, May-24, Volume: 46, Issue:1183 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Drug Administration Schedule; Humans; Imiquimod; Keratosis; Photosensitivity Disorders; Skin Neoplasms	2004
[Treatment of actinic keratosis with topical imiquimod (Aldara): the cutaneous erosion appears beneficial]. Annales de dermatologie et de venereologie, 2004, Volume: 131, Issue:4 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Humans; Imiquimod; Keratosis; Photosensitivity Disorders	2004
Gene expression in actinic keratoses: pharmacological modulation by imiquimod. The British journal of dermatology, 2004, Volume: 151, Issue:6 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Apoptosis; Cell Adhesion Molecules; Cytokines; Gene Expression Regulation; Genes, p53; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Membrane Glycoproteins; Middle Aged; Neoplasms, Radiation-Induced; Precancerous Conditions; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptors	2004
Imiquimod 5% cream for the treatment of actinic keratoses. Skin therapy letter, 2005, Volume: 10, Issue:2 Topics: Adjuvants, Immunologic; Aminoquinolines; Humans; Imiquimod; Keratosis; Photochemotherapy	2005
Aggressive undifferentiated squamous cell carcinoma in an immunosuppressed patient after kidney transplantation. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2005, Volume: 3, Issue:1 Topics: Acitretin; Adjuvants, Immunologic; Administration, Oral; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Counseling; Cyclosporine; Follow-Up Studies; Humans; Imiquimod; Immunocompromised Host; Immunosuppressive Agents; Keratolytic Agents; Keratosis; Kidney Transplantation; Male; Middle Aged; Ointments; Skin; Skin Neoplasms; Sunscreening Agents; Time Factors	2005
Reports of immunologic reactions to imiquimod: an assessment of actinic keratoses and treatment concerns in this era of litigation lotto. Dermatology online journal, 2005, Dec-01, Volume: 11, Issue:3 Topics: Adjuvants, Immunologic; Aminoquinolines; Drug Hypersensitivity; Humans; Imiquimod; Keratosis; Malpractice	2005
Treatment of precancerous and cancerous lesions of chronic arsenicism with 5% imiquimod cream. Archives of dermatology, 2006, Volume: 142, Issue:4 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Arsenic; Arsenic Poisoning; Chronic Disease; Forearm; Humans; Imiquimod; Keratosis; Male; Precancerous Conditions; Skin Neoplasms; Water Pollutants, Chemical	2006
Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses. Acta dermato-venereologica, 2006, Volume: 86, Issue:4 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratoacanthoma; Keratosis; Male; Middle Aged; Skin Neoplasms; Ultraviolet Rays	2006
Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod. International journal of dermatology, 2006, Volume: 45, Issue:12 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Drug Eruptions; Humans; Imiquimod; Keratosis; Male; Ointments; Psoriasis; Scalp Dermatoses	2006
Treating actinic keratoses with imiquimod. Australian family physician, 2007, Volume: 36, Issue:5 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Squamous Cell; Cryotherapy; Facial Dermatoses; Humans; Imiquimod; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Scalp Dermatoses; Skin Neoplasms	2007
Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment. The American Journal of dermatopathology, 2007, Volume: 29, Issue:3 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Biomarkers, Tumor; Bowen's Disease; Carcinoma in Situ; Carcinoma, Basal Cell; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Inflammation; Keratosis; Male; Melanoma; Middle Aged; Skin Neoplasms	2007
Severe reaction to 5% imiquimod cream with excellent clinical and cosmetic outcomes. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:4 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Cheilitis; Drug Eruptions; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Ointments; Time Factors; Treatment Outcome	2007
5% topical imiquimod tolerance in transplant recipients. Dermatology (Basel, Switzerland), 2007, Volume: 215, Issue:2 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Drug Administration Schedule; Female; Humans; Imiquimod; Immunocompromised Host; Keratosis; Male; Middle Aged; Retrospective Studies; Skin; Skin Neoplasms; Transplantation; Treatment Outcome; Ultraviolet Rays; Warts	2007
Squamous cell carcinoma on the scalp following treatment with 5% imiquimod cream. Clinical and experimental dermatology, 2007, Volume: 32, Issue:5 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Imiquimod; Keratosis; Male; Radiodermatitis; Scalp; Skin Neoplasms	2007
Pharmacoeconomic analysis of the treatment of multiple actinic keratoses. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:1 Topics: Aminolevulinic Acid; Aminoquinolines; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cryotherapy; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photochemotherapy; Treatment Outcome	2008
Detection of human papillomavirus and response to topical 5% imiquimod in a case of stucco keratosis. The British journal of dermatology, 2000, Volume: 143, Issue:4 Topics: Aged; Aminoquinolines; DNA, Viral; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Molecular Sequence Data; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Tumor Virus Infections	2000
[Proven and promising for the future]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2001, Volume: 52, Issue:1 Topics: Aminoquinolines; Anus Diseases; Clinical Trials as Topic; Condylomata Acuminata; Female; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Ointments; Recurrence; Time Factors	2001
Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. The British journal of dermatology, 2001, Volume: 144, Issue:5 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Follow-Up Studies; Humans; Imiquimod; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Precancerous Conditions; Recurrence; Scalp Dermatoses; Skin Neoplasms	2001
Topical imiquimod to treat intraepidermal carcinoma. Archives of dermatology, 2001, Volume: 137, Issue:6 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Nose; Photosensitivity Disorders; Precancerous Conditions; Skin Neoplasms; Thorax	2001
Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms. International journal of dermatology, 2002, Volume: 41 Suppl 1 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Bowen's Disease; Cicatrix; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis; Paget Disease, Extramammary; Photochemotherapy; Pruritus; Randomized Controlled Trials as Topic; Skin Neoplasms	2002
Imiquimod stimulates innate and cell mediated immunity which controls virus infections and tumors. International journal of dermatology, 2002, Volume: 41 Suppl 1 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Carcinoma, Basal Cell; Condylomata Acuminata; Humans; Imiquimod; Immunity, Cellular; Immunity, Innate; Interferon Inducers; Keratosis; Papillomaviridae; Papillomavirus Infections	2002